Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$602K Buy
2,010
+6
+0.3% +$1.68K 0.02% 195
2023
Q3
$548K Buy
2,004
+8
+0.4% +$2.29K 0.02% 193
2023
Q2
$609K Hold
1,996
0.02% 192
2023
Q1
$570K Hold
1,996
0.02% 194
2022
Q4
$488K Hold
1,996
0.02% 203
2022
Q3
$404K Hold
1,996
0.02% 210
2022
Q2
$397K Hold
1,996
0.01% 221
2022
Q1
$534K Hold
1,996
0.02% 215
2021
Q4
$534K Hold
1,996
0.02% 223
2021
Q3
$526K Hold
1,996
0.02% 215
2021
Q2
$518K Hold
1,996
0.02% 218
2021
Q1
$486K Hold
1,996
0.02% 223
2020
Q4
$489K Sell
1,996
-295
-13% -$66.8K 0.02% 205
2020
Q3
$477K Hold
2,291
0.02% 188
2020
Q2
$413K Hold
2,291
0.02% 184
2020
Q1
$381K Hold
2,291
0.02% 188
2019
Q4
$481K Hold
2,291
0.02% 191
2019
Q3
$496K Buy
+2,291
New +$491K 0.02% 193

Other funds holding SYK

Cannell & Co's SYK Position: Q4 2023 in Review

Cannell & Co increased its Stryker (SYK) stake by 0.3% in Q4 2023, buying an estimated $1.68K and bringing the position to 2,010 shares worth $602K. The position accounts for 0.02% of the portfolio, ranked #195.

Cannell & Co first reported a position in SYK in Q3 2019 and has held it in 18 quarters since. The position peaked at $609K in Q2 2023. 1,884 funds tracked by Wall St. Rank hold SYK as of Q4 2023.

  • Cannell & Co held 2,010 shares of Stryker worth $602K as of Q4 2023.
  • Cannell & Co bought 6 Stryker shares in Q4 2023, an estimated $1.68K.
  • Stryker made up 0.02% of Cannell & Co's portfolio in Q4 2023, its #195 holding.
  • Cannell & Co first reported a position in Stryker in Q3 2019 and has held it in 18 quarters since.
  • Cannell & Co's Stryker position peaked at $609K in Q2 2023.
  • 1,884 funds tracked by Wall St. Rank held Stryker as of Q4 2023.

Based on Cannell & Co's 13F filing for Q4 2023, filed 5 Feb 2024.